Performances of a Solution to Semi-Automatically Fill eCRF with Data from the Electronic Health Record: Protocol for a Prospective Individual Participant Data Meta-Analysis.

Clinical Trial Protocols as Topic Clinical trial as topic Data collection Health Information Interoperability eSource

Journal

Studies in health technology and informatics
ISSN: 1879-8365
Titre abrégé: Stud Health Technol Inform
Pays: Netherlands
ID NLM: 9214582

Informations de publication

Date de publication:
16 Jun 2020
Historique:
entrez: 24 6 2020
pubmed: 24 6 2020
medline: 26 8 2020
Statut: ppublish

Résumé

Clinical trial data collection still relies on a manual entry from information available in the medical record. This process introduces delay and error risk. Automating data transfer from Electronic Health Record (EHR) to Electronic Data Capture (EDC) system, under investigators' supervision, would gracefully solve these issues. The present paper describes the design of the evaluation of a technology allowing EHR to act as eSource for clinical trials. As part of the EHR2EDC project, for 6 ongoing clinical trials, running at 3 hospitals, a parallel semi-automated data collection using such technology will be conducted focusing on a limited scope of data (demographic data, local laboratory results, concomitant medication and vital signs). The evaluation protocol consists in an individual participant data prospective meta-analysis comparing regular clinical trial data collection to the semi-automated one. The main outcome is the proportion of data correctly entered. Data quality and associated workload for hospital staff will be compared as secondary outcomes. Results should be available in 2020.

Identifiants

pubmed: 32570408
pii: SHTI200184
doi: 10.3233/SHTI200184
doi:

Types de publication

Journal Article Meta-Analysis

Langues

eng

Pagination

367-371

Auteurs

Nicolas Griffon (N)

WIND Department, AP-HP, Paris, France.
LIMICS, U1142, Inserm, France.

Helena Pereira (H)

HEGP, AP-HP, France.

Juliette Djadi-Prat (J)

HEGP, AP-HP, France.

María Teresa García (MT)

Hospital 12 de Octubre, Madrid, Spain.

Sara Testoni (S)

IRST-IRCCS, Meldola, Italy.

Manon Cariou (M)

Sanofi R&D, Paris, France.

Jacques Hilbey (J)

LIMICS, U1142, Inserm, France.

Aurèle N'Dja (A)

Sanofi R&D, Paris, France.

Grégory Navarro (G)

Janssen Pharmaceutica NV, Beerse, Belgium.

Nicola Gentili (N)

IRST-IRCCS, Meldola, Italy.

Oriana Nanni (O)

IRST-IRCCS, Meldola, Italy.

Massimo Raineri (M)

Janssen Pharmaceutica NV, Beerse, Belgium.

Gilles Chatellier (G)

HEGP, AP-HP, France.

Agustín Gómez De La Camara (A)

Hospital 12 de Octubre, Madrid, Spain.
CIBERESP.

Martine Lewi (M)

Janssen Pharmaceutica NV, Beerse, Belgium.

Mats Sundgren (M)

AstraZeneca, Göteborg, Sweden.

Christel Daniel (C)

WIND Department, AP-HP, Paris, France.
LIMICS, U1142, Inserm, France.

Almenia Garvey (A)

Icon PLC, Paris, France.

Marija Todorovic (M)

Janssen Pharmaceutica NV, Beerse, Belgium.

Nadir Ammour (N)

Sanofi R&D, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH